Evaxion will present new biomarker and immune data obtained from the ongoing phase 2 trial. These will further add to EVX-01’s already strong clinical data package.

SOUTH SAN FRANCISCO, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Corvus or the Company) (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today provided a ...

Acquired In-Process Research and Development expense: Acquired in-process research and development expense was $51.7 million ...

The brain's immune cells removed plaques and helped restore a healthier environment in the brains of immunized patients. For over 30 years, scientists have focused on treating Alzheimer’s disease by ...

Walk MS is two weeks away, and more than 1,500 people in the area are hard at work fundraising and building their teams. Thanks to funds raised at events like Walk MS, ...

What is Celiac disease? Celiac disease is caused when a person’s immune system reacts abnormally to a protein called gluten.

Rheumatologists and cardiologists have long co-managed patients out of necessity and without much formal collaboration or ...

Patients with skin disease adhering to a proper diet may experience better treatment responses and a reduced risk of adverse ...

Harvard Medical School scientists have identified a key protein in the human immune system that drives inflammatory and ...

Physician-scientists Preet Chaudhary, M.D., Ph.D., and Michael Selsted, M.D., Ph.D., both from the Keck School of Medicine, have been elected as senior members of the National Academy of Inventors ...

Mucormycosis, a fungal infection caused by Mucorales, has high mortality rates in people with weakened immune systems and those suffering from severe trauma like burns, blast injuries or victims of ...

Mucormycosis, a fungal infection caused by Mucorales, has high mortality rates in people with weakened immune systems and ...